Diacylglycerol kinase δ modulates akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2)

Journal of Biological Chemistry

Volumn 288, Issue 3, 2013, Pages 1439-1447

  Crotty, Tracy M ^a   Nakano, Tomoyuki ^a   Stafforini, Diana M ^a,b   Topham, Matthew K ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKT ACTIVATION; AKT PHOSPHORYLATION; ARRESTINS; CANCER THERAPEUTICS; CRITICAL TASKS; CULTURED CELL; DEPHOSPHORYLATIONS; DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; FEED-BACK LOOP; LEUCINE-RICH REPEATS; PLECKSTRIN HOMOLOGY DOMAINS; PROTEIN PHOSPHATASE; RECEPTOR TYROSINE KINASE; SIGNALING PATHWAYS;

ACTIVATION ANALYSIS; AMINO ACIDS; CELL DEATH; CELL PROLIFERATION; DISEASES; LIPIDS; PHOSPHATASES; PHOSPHORYLATION; PROTEINS; SIGNALING;

GLYCEROL;

BETA ARRESTIN 1; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE DELTA; PHOSPHOPROTEIN PHOSPHATASE; PLECKSTRIN HOMOLOGY DOMAIN LEUCINE RICH REPEAT PROTEIN PHOSPHATASE 2; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ARRESTINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DIACYLGLYCEROL KINASE; DIGLYCERIDES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 84872744101     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.407379     Document Type: Article

References (46)

1. Altomare, D. A., and Testa, J. R. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464 (Pubitemid 41637985)
2. Sparks, C. A., and Guertin, D. A. (2010) Targeting mTOR. Prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29, 3733-3744
3. Gao, T., Furnari, F., and Newton, A. C. (2005) PHLPP. A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13-24 (Pubitemid 40444644)
4. Brognard, J., Sierecki, E., Gao, T., and Newton, A. C. (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 25, 917-931 (Pubitemid 46436532)
5. Hellwinkel, O. J., Rogmann, J. P., Asong, L. E., Luebke, A. M., Eichelberg, C., Ahyai, S., Isbarn, H., Graefen, M., Huland, H., and Schlomm, T. (2008) A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer. BJU International 101, 1454-1460 (Pubitemid 351623985)
6. Chen, M., Pratt, C. P., Zeeman, M. E., Schultz, N., Taylor, B. S., O'Neill, A., Castillo-Martin, M., Nowak, D. G., Naguib, A., Grace, D. M., Murn, J., Navin, N., Atwal, G. S., Sander, C., Gerald, W. L., Cordon-Cardo, C., Newton, A. C., Carver, B. S., and Trotman, L. C. (2011) Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 20, 173-186
7. Liu, J., Stevens, P. D., and Gao, T. (2011) mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. J. Biol. Chem. 286, 6510-6520
8. Li, X., Liu, J., and Gao, T. (2009) α-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt. Mol. Cell. Biol. 29, 6192-6205
9. Li, X., Yang, H., Liu, J., Schmidt, M. D., and Gao, T. (2011) Scribblemediated membrane targeting of PHLPP1 is required for its negative regulation of Akt. EMBO Rep. 12, 818-824
10. Molina, J. R., Agarwal, N. K., Morales, F. C., Hayashi, Y., Aldape, K. D., Cote, G., and Georgescu, M. M. (2012) PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene 31, 1264-1274
11. Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., and Wang, L. (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259-266
12. Griner, E. M., and Kazanietz, M. G. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7, 281-294 (Pubitemid 46480971)
13. Shulga, Y. V., Topham, M. K., and Epand, R. M. (2011) Regulation and functions of diacylglycerol kinases. Chem. Rev. 111, 6186-6208
14. Cai, J., Crotty, T. M., Reichert, E., Carraway, K. L., 3rd, Stafforini, D. M., and Topham, M. K. (2010) Diacylglycerol kinase α and protein kinase C(α) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8. J. Biol. Chem. 285, 6952-6959
15. Chibalin, A. V., Leng, Y., Vieira, E., Krook, A., Björnholm, M., Long, Y. C., Kotova, O., Zhong, Z., Sakane, F., Steiler, T., Nylén, C., Wang, J., Laakso, M., Topham, M. K., Gilbert, M., Wallberg-Henriksson, H., and Zierath, J. R. (2008) Downregulation of diacylglycerol kinase α contributes to hyperglycemia-induced insulin resistance. Cell 132, 375-386 (Pubitemid 351191998)
16. Nelson, C. D., Perry, S. J., Regier, D. S., Prescott, S. M., Topham, M. K., and Lefkowitz, R. J. (2007) Targeting of diacylglycerol degradation to M1 muscarinic receptors by α-arrestins. Science 315, 663-666 (Pubitemid 46214713)
17. Sakane, F., Imai, S., Kai, M., Wada, I., and Kanoh, H. (1996) Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J. Biol. Chem. 271, 8394-8401 (Pubitemid 26108676)
18. Al-Salihi, M. A., Ulmer, S. C., Doan, T., Nelson, C. D., Crotty, T., Prescott, S. M., Stafforini, D. M., and Topham, M. K. (2007) Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific Eprostanoid receptors and tumor necrosis factor-α converting enzyme. Cell. Signal. 19, 1956-1963 (Pubitemid 47081385)
19. Sakane, F., Imai, S., Yamada, K., Murakami, T., Tsushima, S., and Kanoh, H. (2002) Alternative splicing of the human diacylglycerol kinase α gene generates two isoforms differing in their expression patterns and in regulatory functions. J. Biol. Chem. 277, 43519-43526 (Pubitemid 35285741)
20. Sachs, M., Brohmann, H., Zechner, D., Müller, T., Hülsken, J., Walther, I., Schaeper, U., Birchmeier, C., and Birchmeier, W. (2000) Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 150, 1375-1384
21. Engelman, J. A., Jänne, P. A., Mermel, C., Pearlberg, J., Mukohara, T., Fleet, C., Cichowski, K., Johnson, B. E., and Cantley, L. C. (2005) ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 102, 3788-3793 (Pubitemid 40354690)
22. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N., and Avruch, J. (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8, 69-81 (Pubitemid 28104519)
23. Crotty, T., Cai, J., Sakane, F., Taketomi, A., Prescott, S. M., and Topham, M. K. (2006) Diacylglycerol kinase α regulates protein kinase C and epidermal growth factor receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 15485-15490 (Pubitemid 44625618)
24. Pawson, T., and Scott, J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (Pubitemid 28028310)
25. Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., and Pei, G. (2009) Deficiency of a α-arrestin-2 signal complex contributes to insulin resistance. Nature 457, 1146-1149
26. Leitges, M., Plomann, M., Standaert, M. L., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., and Farese, R. V. (2002) Knockout of PKC α enhances insulin signaling through PI3K. Mol. Endocrinol. 16, 847-858 (Pubitemid 34297752)
27. Tanaka, Y., Gavrielides, M. V., Mitsuuchi, Y., Fujii, T., and Kazanietz, M. G. (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem. 278, 33753-33762 (Pubitemid 37553209)
28. Chen, W. S., Xu, P. Z., Gottlob, K., Chen, M. L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., Kadowaki, T., and Hay, N. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (Pubitemid 32843832)
29. Pao, W., and Chmielecki, J. (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat. Rev. Cancer 10, 760-774
30. Baird, W. M., and Boutwell, R. K. (1971) Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res. 31, 1074-1079
31. Blumberg, P. M., Delclos, K. B., Dunn, J. A., Jaken, S., Leach, K. L., and Yeh, E. (1983) Phorbol ester receptors and the in vitro effects of tumor promoters. Ann. N.Y. Acad. Sci. 407, 303-315 (Pubitemid 13055460)
32. Caino, M. C., Lopez-Haber, C., Kim, J., Mochly-Rosen, D., and Kazanietz, M. G. (2012) Protein kinase Cα is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes. Oncogene 31, 2593-2600
33. Oliva, J. L., Caino, M. C., Senderowicz, A. M., and Kazanietz, M. G. (2008) S-Phase-specific activation of PKCα induces senescence in non-small cell lung cancer cells. J. Biol. Chem. 283, 5466-5476
34. Oster, H., and Leitges, M. (2006) Protein kinase C α but not PKCα suppresses intestinal tumor formation in ApcMin/α mice. Cancer Res. 66, 6955-6963 (Pubitemid 44197670)
35. Gao, T., Brognard, J., and Newton, A. C. (2008) The phosphatase PHLPP controls the cellular levels of protein kinase C. J. Biol. Chem. 283, 6300-6311
36. Liu, J., Stevens, P. D., Li, X., Schmidt, M. D., and Gao, T. (2011) PHLPPmediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Mol. Cell. Biol. 31, 4917-4927
37. Luo, B., Prescott, S. M., and Topham, M. K. (2003) Association of diacylglycerol kinase α with protein kinase C α. Spatial regulation of diacylglycerol signaling. J. Cell Biol. 160, 929-937 (Pubitemid 36350847)
38. Zhong, X. P., Hainey, E. A., Olenchock, B. A., Jordan, M. S., Maltzman, J. S., Nichols, K. E., Shen, H., and Koretzky, G. A. (2003) Enhanced T cell responses due to diacylglycerol kinase α deficiency. Nat. Immunol. 4, 882-890 (Pubitemid 37098659)
39. Yasuda, S., Kai, M., Imai, S., Takeishi, K., Taketomi, A., Toyota, M., Kanoh, H., and Sakane, F. (2009) Diacylglycerol kinase α augments C-Raf activity and B-Raf/C-Raf heterodimerization. J. Biol. Chem. 284, 29559-29570
40. Bacchiocchi, R., Baldanzi, G., Carbonari, D., Capomagi, C., Colombo, E., van Blitterswijk, W. J., Graziani, A., and Fazioli, F. (2005) Activation of α-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase. Blood 106, 2175-2182 (Pubitemid 41291736)
41. Baldanzi, G., Mitola, S., Cutrupi, S., Filigheddu, N., van Blitterswijk, W. J., Sinigaglia, F., Bussolino, F., and Graziani, A. (2004) Activation of diacylglycerol kinase α is required for VEGF-induced angiogenic signaling in vitro. Oncogene 23, 4828-4838 (Pubitemid 38932155)
42. Chianale, F., Rainero, E., Cianflone, C., Bettio, V., Pighini, A., Porporato, P. E., Filigheddu, N., Serini, G., Sinigaglia, F., Baldanzi, G., and Graziani, A. (2010) Diacylglycerol kinase α mediates HGF-induced Rac activation and membrane ruffling by regulating atypical PKC and RhoGDI. Proc. Natl. Acad. Sci. U.S.A. 107, 4182-4187
43. Olenchock, B. A., Guo, R., Carpenter, J. H., Jordan, M., Topham, M. K., Koretzky, G. A., and Zhong, X. P. (2006) Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat. Immunol. 7, 1174-1181 (Pubitemid 44594313)
44. Kakefuda, K., Oyagi, A., Ishisaka, M., Tsuruma, K., Shimazawa, M., Yokota, K., Shirai, Y., Horie, K., Saito, N., Takeda, J., and Hara, H. (2010) Diacylglycerol kinase α knockout mice exhibit lithium-sensitive behavioral abnormalities. PloS ONE 5, e13447
45. Regier, D. S., Higbee, J., Lund, K. M., Sakane, F., Prescott, S. M., and Topham, M. K. (2005) Diacylglycerol kinase regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc. Natl. Acad. Sci. U.S.A. 102, 7595-7600 (Pubitemid 40741016)
46. Rodriguez de Turco, E. B., Tang, W., Topham, M. K., Sakane, F., Marcheselli, V. L., Chen, C., Taketomi, A., Prescott, S. M., and Bazan, N. G. (2001) Diacylglycerol kinase α regulates seizure susceptibility and longterm potentiation through arachidonoyl-inositol lipid signaling. Proc. Natl. Acad. Sci. U.S.A. 98, 4740-4745 (Pubitemid 32295046)